GSIs have been shown to affect not only tumor cell growth via Notch, but also other targets e.g. erbB-4, mToR and Glut1 and thereby affecting other signaling pathways important for tumor growth, nutritional status of the tumor and possibly cancer stem cells [27], [28]. The gene discussed is SLC2A1; the disease is cancer.